Drug Profile
Research programme: PAR-1 antagonists - Onc Bio
Alternative Names: BIO 141Latest Information Update: 11 Jan 2008
Price :
$50
*
At a glance
- Originator Onc Bio
- Class Small molecules
- Mechanism of Action PAR 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 Oct 2005 Preclinical trials in Cancer in USA (unspecified route)